Recurrent COVID-19 pneumonia in the course of chemotherapy: Consequence of a weakened immune system?
Michelangelo LucianiEnrico BentivegnaValerio SpuntarelliPiera Amoriello LambertiGiulio CacioliFlavia Del PortoGiorgio SestiPaolo MartellettiLuciano De BiasePublished in: Journal of medical virology (2020)
One of the objectives that the scientific community is setting itself is to understand whether acquired immunity and the presence of antibodies against acute coronavirus 2 (SARS-CoV-2) antibodies protect against reinfection. Although there are many published papers describing how the re-positivization of nasopharyngeal swab polymerase chain reaction real time (RT-PCR) test and clinical healing of the subject can be justified by numerous reasons and random situations. Our aim is to highlight how there are certain populations more susceptible to re-infection than others. This article is protected by copyright. All rights reserved.
Keyphrases
- sars cov
- respiratory failure
- respiratory syndrome coronavirus
- liver failure
- healthcare
- mental health
- coronavirus disease
- locally advanced
- drug induced
- extracorporeal membrane oxygenation
- randomized controlled trial
- systematic review
- radiation therapy
- meta analyses
- rectal cancer
- real time pcr
- finite element
- chemotherapy induced